Investor Day & Corporate Videos

Corporate Videos

Product Development Update:
Fate Space Screening

Development of HyStem®: Part 1 — Glenn Prestwich, Ph.D.

Development of HyStem®: Parts 2 & 3 — Glenn Prestwich, Ph.D.

Product Development Update:
LifeMap Discovery

Product Development Update: Renevia(TM)

OrthoCyte’s CSO Dr. Arnold Caplan Discusses Product Development

Discussion of Glycosan Acquisition and use of Hydrogels in Tissue Engineering

OrthoCyte’s Chief Scientific Officer Dr. Arnold Caplan – cartilage biology

BioTime 2012 Annual Shareholder Meeting

BioTime Investor Day Presentations

Keynote Speaker -
Andrew von Eschenbach, M.D

Introduction to BioTime -
Michael West, Ph.D.

OrthoCyte’s HyStem Family of Products
- William Tew, Ph.D.

CellCure Nerosciences –
Charles Irving, Ph.D.

OncoCyte – Joseph Wagner, Ph.D.
and Karen Chapman, Ph.D.

OrthoCyte
Arnold I. Caplan, Ph.D.

ReCyte Therapeutics – Steven Kessler,
Ph.D and Shahin Rafii, M.D.

LifeMap Sciences –
David Warshawsky, Ph.D.

Overview of BioTime Investment Opportunities – Peter Garcia